MetaCap

Insight Molecular Diagnostics (IMDX) News

NASDAQ: IMDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

1.97+0.31 (+18.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IMDX news summary

We found 8 recent headlines mentioning Insight Molecular Diagnostics (IMDX): 7 in the past week and 7 in the past 30 days, most often from Nasdaq, GlobeNewswire. IMDX is making an outsized move today, up 18.67% at $1.97, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Healthcare Stocks In Focus - ITOC +17%, EVAX +13%, IMDX +10%; AKAN And EVH See Trading Activity", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Insight Molecular Diagnostics headlines

Stocks mentioned alongside IMDX

Compare IMDX